| SOTK |
Sono-Tek Corporation |
72%
|
Reciprocal relationship from SOTK graph: ng Manager, and Vice President of Application Engineering. Mr. Cichetti has experience in lab testing, process development, project management, and has succes… |
| SOTK |
Sono-Tek Corporation |
72%
|
s from India, with first-class honors. He has also completed the following programs: Advanced Management Program (AMP) at NTU-Berkeley (Haas Business School, California) and Advanced Management Progr… |
| CRO-PREVAIL-INFOWORKS-INC |
CRO-PREVAIL-INFOWORKS-INC |
62%
|
million, partially offset by unrealized and realized gains on digital assets. (b) Investing Activities Net cash used in investing activities was $10.0 million for the year ended December 31, 2025, co… |
| DASH |
DoorDash, Inc. |
62%
|
Reciprocal relationship from DASH graph: Reciprocal relationship from APUS graph: Reciprocal relationship from DASH graph: Reciprocal relationship from APUS graph: Reciprocal relationship from DASH g… |
| HILLUCK-CO-LTD |
HILLUCK-CO-LTD |
62%
|
ess development activities. Previously, Mr. Ji served as an independent director of Trinity Ventures, a venture capital firm, from August 2018 until January of 2025. Mr. Cho has served as the Chief E… |
| HYUNDAI-MOTOR-COMPANY |
HYUNDAI-MOTOR-COMPANY |
62%
|
ess development activities. Previously, Mr. Ji served as an independent director of Trinity Ventures, a venture capital firm, from August 2018 until January of 2025. Mr. Cho has served as the Chief E… |
| LK-VENTURES-CO-LTD |
LK-VENTURES-CO-LTD |
62%
|
ess development activities. Previously, Mr. Ji served as an independent director of Trinity Ventures, a venture capital firm, from August 2018 until January of 2025. Mr. Cho has served as the Chief E… |
| LOKAHI-THERAPEUTICS-INC |
LOKAHI-THERAPEUTICS-INC |
62%
|
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations Overview Apimeds Pharmaceuticals US, Inc. (“APUS,” the “Company,” “we,” “us,” or “our”) is a development-… |
| MINDWAVE-INNOVATIONS-INC |
MINDWAVE-INNOVATIONS-INC |
62%
|
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations Overview Apimeds Pharmaceuticals US, Inc. (“APUS,” the “Company,” “we,” “us,” or “our”) is a development-… |
| MINDWAVE-INNOVATIONS-INC-MINDWAVE-INNOVATIONS-IN |
MINDWAVE-INNOVATIONS-INC-MINDWAVE-INNOVATIONS-IN |
62%
|
manufacturer patient programs, and reform government program reimbursement methodologies for drug products. At the state level, legislatures have increasingly passed legislation and implemented regul… |
| MINDWAVE-LTD |
MINDWAVE-LTD |
62%
|
objective of aligning incentives among stakeholders while maintaining institutional controls. Within our validator framework, we intend to limit protocol participation to policy-permitted activities … |
| NILA-TECHYTRADE-INNOVATIONS-PTE-LTD |
NILA-TECHYTRADE-INNOVATIONS-PTE-LTD |
62%
|
manufacturer patient programs, and reform government program reimbursement methodologies for drug products. At the state level, legislatures have increasingly passed legislation and implemented regul… |
| OPERATIONS-OVERVIEW-APIMEDS-PHARMACEUTICALS-US-I |
OPERATIONS-OVERVIEW-APIMEDS-PHARMACEUTICALS-US-I |
62%
|
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations Overview Apimeds Pharmaceuticals US, Inc. (“APUS,” the “Company,” “we,” “us,” or “our”) is a development-… |
| PARTNERS-CO-LTD |
PARTNERS-CO-LTD |
62%
|
ess development activities. Previously, Mr. Ji served as an independent director of Trinity Ventures, a venture capital firm, from August 2018 until January of 2025. Mr. Cho has served as the Chief E… |
| PHASE-III-MULTI-CENTER-RANDOMIZED-DOUBLE-BLIND-P |
PHASE-III-MULTI-CENTER-RANDOMIZED-DOUBLE-BLIND-P |
62%
|
s an adjunctive therapy for all four types of MS. We intend to explore Apitox as a potential adjunctive therapy through non-registered corporate sponsorship studies to begin determining the appropria… |
| PREVAIL-INFOWORKS-INC |
PREVAIL-INFOWORKS-INC |
62%
|
Merger, on December 1, 2025, we entered into a Securities Purchase Agreement providing for the issuance of senior secured convertible notes in an aggregate maximum principal amount of $129 million, t… |
| SAMSUNG-ELECTRONICS-CO-LTD |
SAMSUNG-ELECTRONICS-CO-LTD |
62%
|
ision, Device Solutions division of Samsung Electronics Co., Ltd. as a Staff Engineer for Firmware Development and Simulator. Since January 2025, Mr. Ji has served as an independent director of LK Ve… |
| TECHYTRADE-FZ-LLC |
TECHYTRADE-FZ-LLC |
62%
|
gapore) ”). TechyTrade FZ LLC is a limited liability company operating under the laws of the Ras Al Khaimah Economic Zone is a wholly owned subsidiary of TechyTrade Singapore (“ TechyTrade (Dubai) ”)… |
